$17.33
-2.6%Omada Health is a U.S.-based virtual-care provider offering clinically validated programs for chronic conditions like cardiometabolic disease, musculoskeletal care, and behavioral health—delivered digitally between doctor visits.
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.
OMDA • NASDAQ
| Omada Health Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
REVENUE | ||||
260.2M | 169.8M | 122.8M | 89.2M | |
GROSS PROFIT | ||||
(89.7M) | (66.9M) | (52.8M) | (46.4M) | |
170.5M | 102.9M | 70M | 42.8M | |
OPERATING INCOME | ||||
(182.5M) | (146.5M) | (136M) | (115.1M) | |
(141.9M) | (110.6M) | (102.2M) | (89M) | |
(40.6M) | (35.9M) | (33.7M) | (26.2M) | |
-12M | -43.7M | -66M | -72.4M | |
PRE-TAX INCOME | ||||
(2.5M) | (4.5M) | (4.7M) | (4.2M) | |
2.8M | -3.7M | 1.1M | -2M | |
-805K | -3.5M | -1.5M | -168K | |
-12.8M | -47.1M | -67.5M | -72.5M | |
NET INCOME | ||||
-12.8M | -47.1M | -67.5M | -72.5M |
OMDA - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | May 08, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 07, 2026 | May 07, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 28, 2026 | June 16, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 06, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 05, 2026 | March 05, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 12, 2026 | January 12, 2026 | 2026 | |
10-Q 10-Q 2025 Q3 Q3 | November 07, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 06, 2025 | November 06, 2025 | 2025 | |
10-Q 10-Q 2025 Q2 Q2 | August 08, 2025 | June 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | August 07, 2025 | August 07, 2025 | 2025 |
Continue your OMDA research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.